Purple Biotech Ltd.(PPBT),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

PPBT Purple Biotech Ltd.

Post-Mkt 08-31 17:28:25 EDT

1.70

+0.02

+1.19%

盘后1.76

+0.06+3.53%

16:10 EDT

High1.74	Low1.67	Vol12.33K
Open1.67	D1 Closing1.68	Amplitude4.17%
Mkt Cap2.77M	Tradable Cap1.58M	Total Shares1.63M
T/O21.11K	T/O Rate1.33%	Tradable Shares927.10K
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"PPBT","market":"US","secType":"STK","nameCN":"Purple Biotech Ltd.","latestPrice":1.7,"timestamp":1788206400000,"preClose":1.68,"halted":0,"volume":12331,"hourTrading":{"tag":"盘后","latestPrice":1.76,"preClose":1.7,"latestTime":"16:10 EDT","volume":11,"amount":19.260000100000003,"timestamp":1788207005026,"change":0.06,"changeRate":0.035294,"amplitude":0.058824},"delay":0,"changeRate":0.011904761904761916,"floatShares":927099,"shares":1626867,"eps":-28.806,"marketStatus":"Post-Mkt","change":0.02,"latestTime":"08-31 17:28:25 EDT","open":1.67,"high":1.74,"low":1.67,"amount":21112,"amplitude":0.041667,"askPrice":1.82,"askSize":122,"bidPrice":1.53,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-28.806,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1788220800000},"marketStatusCode":4,"adr":0,"adrRate":200,"listingDate":1447995600000,"exchange":"NASDAQ","adjPreClose":1.68,"preHourTrading":{"tag":"盘前","latestPrice":1.76,"preClose":1.68,"latestTime":"04:00 EDT","volume":1,"amount":1.76,"timestamp":1788163213594,"change":0.08,"changeRate":0.047619,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":1.76,"preClose":1.7,"latestTime":"16:10 EDT","volume":11,"amount":19.260000100000003,"timestamp":1788207005026,"change":0.06,"changeRate":0.035294,"amplitude":0.058824},"volumeRatio":0.304871,"impliedVol":0.9693,"impliedVolPercentile":0.568},"requestUrl":"/m/hq/s/PPBT/tweets","defaultTab":"tweets","newsList":[{"id":"2657961700","title":"Press Release: Purple Biotech Reports Second Quarter 2026 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2657961700","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657961700?lang=en_us&edition=fundamental","pubTime":"2026-08-07 19:00","pubTimestamp":1786100400,"startTime":"0","endTime":"0","summary":"masking strategy and supports the planned advancement of IM1240 toward a. -- IM1240 demonstrated an approximately 8-fold longer half-life and 16-fold. greater systemic exposure compared to the non-capped variant, together. with dose-proportional pharmacokinetics and a broad therapeutic window.-- The CAPTN-3 masking strategy mitigated peripheral T-cell activation and. systemic cytokine release. IM1240 induced minimal IL-6 and TNF-<ALPHA> at. a dose of 10 mg/kg, whereas the non-capped variant induced robust. cytokine release at a dose of 0.03 mg/kg.Generated new patient-derived tumor data supporting IM1240's differentiated mechanism and anti-tumor activity-- Data generated in collaboration with the laboratory of Amir Horowitz, PhD,at the Tisch Cancer Institute at the Icahn School of Medicine at Mount","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4581","BK4097","PPBT","BK4585","BK4007","TLS","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655361598","title":"Purple Biotech Ltd Expected to Post a Loss of 40 Cents a Share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2655361598","media":"Reuters","labels":["dataReport","preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655361598?lang=en_us&edition=fundamental","pubTime":"2026-07-31 21:17","pubTimestamp":1785503825,"startTime":"0","endTime":"0","summary":"Purple Biotech Ltd <PPBT.OQ> expected to post a loss of40cents a share - Earnings PreviewPurple Biotech LtdPPBT.OQ,PPBT.Ois expected to  show no change in quarterly revenue when it reports  results on August 4  for the period ending June 30 2026LSEG's mean analyst estimate for Purple Biotech Ltd is for a loss of 40 cents per share.The one available analyst rating on the shares is \"buy\".The mean earnings estimate of analysts was unchanged in the last three months. Wall Street's median 12-month price target for Purple Biotech Ltd is $30.00, about 2,089.8% above its last closing price of $1.37This summary was machine generated July 31 at 13:17 GMT.  All figures in US dollars unless otherwise stated.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260731:nL8N43X1Z1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PPBT","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642128458","title":"Purple Biotech Says Preclinical Study Supports Advancing IM1240 to First-in-Human Trial in 2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2642128458","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642128458?lang=en_us&edition=fundamental","pubTime":"2026-06-11 20:24","pubTimestamp":1781180688,"startTime":"0","endTime":"0","summary":"Purple Biotech  said Thursday that a non-GLP toxicology study in non-human primates supports advancing its IM1240 drug candidate toward a first-in-human clinical study in 2027.IM1240 demonstrated anti-tumor activity across PD-1- and chemotherapy-resistant patient-derived tumor samples in head and neck, bladder, and lung cancers, the company said.The company said that preclinical data from the study demonstrated IM1240 showing an 8-fold longer half-life, 16-fold greater exposure, and a markedly improved cytokine-release safety profile compared to non-capped variants.Purple Biotech shares were down 19% in Thursday's premarket activity.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4581","PPBT","BK4585","XBI","BK4588","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642848202","title":"Purple Biotech presents new IM1240 data at EACR","url":"https://stock-news.laohu8.com/highlight/detail?id=2642848202","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642848202?lang=en_us&edition=fundamental","pubTime":"2026-06-11 20:12","pubTimestamp":1781179976,"startTime":"0","endTime":"0","summary":"Purple Biotech (PPBT) announced the presentation of new preclinical data from its CAPTN-3 program, IM1240, at the European Association for Cancer R...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/purple-biotech-presents-new-im1240-data-at-eacr-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/purple-biotech-presents-new-im1240-data-at-eacr-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","BK4007","PPBT","BK4588","EPV","XBI","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637108876","title":"Purple Biotech files $200M mixed securities shelf","url":"https://stock-news.laohu8.com/highlight/detail?id=2637108876","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637108876?lang=en_us&edition=fundamental","pubTime":"2026-05-21 05:35","pubTimestamp":1779312938,"startTime":"0","endTime":"0","summary":"17:30 EDT Purple Biotech (PPBT) files $200M mixed securities shelf Published first on TheFly – the ultimate source for real-time, market-moving bre...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/purple-biotech-files-200m-mixed-securities-shelf-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/purple-biotech-files-200m-mixed-securities-shelf-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","PPBT","XBI","BK4581","BK4588","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636838924","title":"Purple Biotech Ltd reports results for the quarter ended March 31 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2636838924","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636838924?lang=en_us&edition=fundamental","pubTime":"2026-05-19 15:02","pubTimestamp":1779174176,"startTime":"0","endTime":"0","summary":"Purple Biotech Ltd reports results for the quarter ended March 31 - Earnings SummaryPurple Biotech Ltd PPBT.OQ reported quarterly adjusted earnings of 9 cents per share for the quarter ended March 31.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260519:nL8N41W0DC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PPBT","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636728024","title":"Analysts Are Bullish on These Healthcare Stocks: Purple Biotech (PPBT), Satellos Bioscience (MSLE)","url":"https://stock-news.laohu8.com/highlight/detail?id=2636728024","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636728024?lang=en_us&edition=fundamental","pubTime":"2026-05-18 18:10","pubTimestamp":1779099020,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Purple Biotech (PPBT) and Satellos Bioscience (MSLE)...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-these-healthcare-stocks-purple-biotech-ppbt-satellos-bioscience-msle-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-these-healthcare-stocks-purple-biotech-ppbt-satellos-bioscience-msle-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","LU0128526141.USD","BK4112","BK4139","BLSG","BK4581","BK4137","PPBT","BK4007","LABU","BK4588","MSCLF","BLSX","LU0029874061.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635598770","title":"Purple Biotech Ltd  expected to post a loss of 38 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2635598770","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635598770?lang=en_us&edition=fundamental","pubTime":"2026-05-15 14:03","pubTimestamp":1778825016,"startTime":"0","endTime":"0","summary":"Purple Biotech Ltd  expected to post a loss of38cents a share - Earnings Preview Purple Biotech Ltd PPBT.OQ, PPBT.O is expected to  show no change in quarterly revenue when it reports  results on May ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260515:nL8N41S0DG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PPBT","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622075355","title":"Purple Biotech announces collaboration with Converge Bio","url":"https://stock-news.laohu8.com/highlight/detail?id=2622075355","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622075355?lang=en_us&edition=fundamental","pubTime":"2026-03-25 20:17","pubTimestamp":1774441032,"startTime":"0","endTime":"0","summary":"Purple Biotech (PPBT) announced a collaboration with Converge Bio to accelerate and enhance Purple Biotech’s next-generation tri-specific antibody ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/purple-biotech-announces-collaboration-with-converge-bio-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/purple-biotech-announces-collaboration-with-converge-bio-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4581","XBI","BK4007","BK4588","BK4585","PPBT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620731133","title":"Purple Biotech Is Building What Could Be the Next Generation of Cancer Immunotherapy (NASDAQ: PPBT)","url":"https://stock-news.laohu8.com/highlight/detail?id=2620731133","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620731133?lang=en_us&edition=fundamental","pubTime":"2026-03-20 21:30","pubTimestamp":1774013431,"startTime":"0","endTime":"0","summary":"WSW, NY, March 20th, 2026, FinanceWire Cancer immunotherapy has already had its first revolution. Checkpoint inhibitors changed the treatment lands...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/newswire/purple-biotech-is-building-what-could-be-the-next-generation-of-cancer-immunotherapy-nasdaq-ppbt?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/newswire/purple-biotech-is-building-what-could-be-the-next-generation-of-cancer-immunotherapy-nasdaq-ppbt?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PSQ","BK4588","SQQQ","TSYW.SI","TQQQ","NQmain","NVIW.SI","QYLG","JEPQ",".IXIC","QLD","PPBT","GPIQ","XBI","BK4585","QQQY","QQQE","USAW.SI","BK4007","BK4581","QID","QQQJ","MNQmain","USJW.SI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620207710","title":"Patent Cliff Risk: How Expiring Protections Threaten Purple Biotech’s Future Exclusivity and Returns","url":"https://stock-news.laohu8.com/highlight/detail?id=2620207710","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620207710?lang=en_us&edition=fundamental","pubTime":"2026-03-20 14:01","pubTimestamp":1773986474,"startTime":"0","endTime":"0","summary":"Purple Biotech Ltd. (PPBT) has disclosed a new risk, in the Trade Secrets category. The analyst notes that Purple Biotech Ltd. faces meaningful exp...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/patent-cliff-risk-how-expiring-protections-threaten-purple-biotechs-future-exclusivity-and-returns?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/patent-cliff-risk-how-expiring-protections-threaten-purple-biotechs-future-exclusivity-and-returns?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4581","XBI","BK4588","BK4585","PPBT","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620297304","title":"Purple Biotech regains compliance with Nasdaq","url":"https://stock-news.laohu8.com/highlight/detail?id=2620297304","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620297304?lang=en_us&edition=fundamental","pubTime":"2026-03-17 19:31","pubTimestamp":1773747097,"startTime":"0","endTime":"0","summary":"Purple Biotech (PPBT) received confirmation from the Listing Qualifications Department of Nasdaq that the company had regained compliance with the ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/purple-biotech-regains-compliance-with-nasdaq-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/purple-biotech-regains-compliance-with-nasdaq-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PPBT","BK4007","BK4585","BK4588","NQmain","BK4581","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619710194","title":"Israel's Purple Biotech Q4 net loss widens on impairment charge","url":"https://stock-news.laohu8.com/highlight/detail?id=2619710194","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619710194?lang=en_us&edition=fundamental","pubTime":"2026-03-13 20:10","pubTimestamp":1773403815,"startTime":"0","endTime":"0","summary":"Israel's Purple Biotech Q4 net loss widens on impairment chargeOverviewIsrael immunotherapy developer's Q4 net loss widened on a $20.5 mln impairment chargeAdjusted operating loss for Q4 increased due","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260313:nL1N4010HR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PPBT","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619194161","title":"Press Release: Purple Biotech Reports Fourth Quarter and Full Year 2025 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2619194161","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619194161?lang=en_us&edition=fundamental","pubTime":"2026-03-13 20:00","pubTimestamp":1773403200,"startTime":"0","endTime":"0","summary":"Focus shifted to development of first tri-specific antibody from the CAPTN-3 platform, IM1240, targeting 5T4 tumor-associated antigen, and second tri-specific antibody, IM1305, named as development candidate, targeting TROP2. Achieved toxicology and manufacturing milestones for IM1240, demonstrating an expanded therapeutic window and commercially viable yield. Total Cash Position of $9.5 million as of December 31, 2025, expected to provide runway into 2027. \"In 2025, we focused on the CAPTN-3 platform and the value it can generate for patients and shareholders, naming a second tri-specific antibody from the platform, IM1305, and strengthening the preclinical data package for the first tri-specific antibody, IM1240. In addition, the capital we raised in 2025 is expected to provide runway into 2027, covering preparations for IM1240 Phase 1 study initiation,\" said Gil Efron, Purple Biotech CEO. \"During the past year, we made efforts to partner both CM24 and NT219 and, as previously report","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Press Release: Purple Biotech Reports Fourth Quarter and Full Year 2025 Financial Results","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XBI","BK4585","BK4007","BK4581","PPBT","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619191135","title":"Purple Biotech Ltd  expected to post a loss of $3.40 a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2619191135","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619191135?lang=en_us&edition=fundamental","pubTime":"2026-03-13 19:39","pubTimestamp":1773401946,"startTime":"0","endTime":"0","summary":"Purple Biotech Ltd  expected to post a loss of $3.40 a share - Earnings Preview Purple Biotech Ltd PPBT.OQ, PPBT.O is expected to  show no change in quarterly revenue when it reports  results on March","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260313:nL8N4010YS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PPBT","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614969218","title":"NASDAQ TRADE HALT CONTINUES  HALT NEWS PENDING AT 07:59 PM","url":"https://stock-news.laohu8.com/highlight/detail?id=2614969218","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614969218?lang=en_us&edition=fundamental","pubTime":"2026-02-28 08:59","pubTimestamp":1772240384,"startTime":"0","endTime":"0","summary":"NASDAQ TRADE HALT CONTINUES  HALT NEWS PENDING AT 07:59 PM","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260228:nAQN2LO82B:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PPBT","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614916896","title":"Purple Biotech trading halted, news pending","url":"https://stock-news.laohu8.com/highlight/detail?id=2614916896","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614916896?lang=en_us&edition=fundamental","pubTime":"2026-02-28 08:50","pubTimestamp":1772239834,"startTime":"0","endTime":"0","summary":"19:50 EST Purple Biotech (PPBT) trading halted, news pending Published first on TheFly – the ultimate source for real-time, market-moving breaking ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/purple-biotech-trading-halted-news-pending-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/purple-biotech-trading-halted-news-pending-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","PPBT","BK4007","BK4585","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614752858","title":"Purple Biotech Ltd  expected to post a loss of 34 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2614752858","media":"Reuters","labels":["dataReport","preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614752858?lang=en_us&edition=fundamental","pubTime":"2026-02-27 20:18","pubTimestamp":1772194693,"startTime":"0","endTime":"0","summary":"Purple Biotech Ltd  expected to post a loss of34cents a share - Earnings Preview Purple Biotech Ltd PPBT.OQ, PPBT.O is expected to  show no change in quarterly revenue when it reports  results on Marc","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260227:nL8N3ZN1CE:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","PPBT"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.purple-biotech.com","stockEarnings":[{"period":"1week","weight":0.0701},{"period":"1month","weight":0.2174},{"period":"3month","weight":-0.4381},{"period":"6month","weight":-0.6203},{"period":"1year","weight":-0.926},{"period":"ytd","weight":-0.7445}],"compareEarnings":[{"period":"1week","weight":0.0047},{"period":"1month","weight":0.0547},{"period":"3month","weight":0.017},{"period":"6month","weight":0.1215},{"period":"1year","weight":0.1856},{"period":"ytd","weight":0.1282}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Purple Biotech Ltd., a clinical-stage company, focuses on developing therapies to overcome tumor immune evasion and drug resistance for cancer patients in the United States. Its oncology pipeline includes CM24, a humanized monoclonal antibody that blocks the interactions of carcinoembryonic antigen related cell adhesion molecule 1 as a combination therapy with anti-PD-1 checkpoint inhibitors, which is in Phase 2 clinical trial for the treatment of pancreatic ductal adenocarcinoma; NT219, a small molecule that targets and inhibits insulin receptor substrate 1 and 2, and signal transducer and activator of transcription, which is in Phase 1/2 clinical trials for the treatment recurrent and/or metastatic squamous cell carcinoma of the head and neck cancer or colorectal adenocarcinoma; and IM1240, a multi-valent antibody designed to activate anti-tumoral immune response against 5T4-positive tumors, which is in preclinical stage. The company has collaboration agreement with Bristol Myers Squibb Company to evaluate the combination of CM24 with the PD-1 inhibitor nivolumab in addition to chemotherapy. The company was formerly known as Kitov Pharma Ltd and changed its name to Purple Biotech Ltd. in December 2020. The company is headquartered in Rehovot, Israel.","yearOnYearQuotes":[{"month":1,"riseRate":0.363636,"avgChangeRate":0.004044},{"month":2,"riseRate":0.454545,"avgChangeRate":-0.007421},{"month":3,"riseRate":0.363636,"avgChangeRate":-0.021595},{"month":4,"riseRate":0.545455,"avgChangeRate":0.003648},{"month":5,"riseRate":0.454545,"avgChangeRate":0.062083},{"month":6,"riseRate":0.181818,"avgChangeRate":-0.06617},{"month":7,"riseRate":0.272727,"avgChangeRate":-0.049318},{"month":8,"riseRate":0.545455,"avgChangeRate":0.421758},{"month":9,"riseRate":0.3,"avgChangeRate":-0.135378},{"month":10,"riseRate":0.5,"avgChangeRate":-0.014741},{"month":11,"riseRate":0.3,"avgChangeRate":-0.035023},{"month":12,"riseRate":0.272727,"avgChangeRate":-0.064801}],"exchange":"NASDAQ","name":"Purple Biotech Ltd.","nameEN":"Purple Biotech Ltd.","securityTypeName":"DR","adrRate":"1:200"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.48.0","shortVersion":"4.48.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Purple Biotech Ltd.(PPBT),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Purple Biotech Ltd.(PPBT) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Purple Biotech Ltd.,PPBT,Purple Biotech Ltd.股票,Purple Biotech Ltd.股票老虎,Purple Biotech Ltd.股票老虎国际,Purple Biotech Ltd.行情,Purple Biotech Ltd.股票行情,Purple Biotech Ltd.股价,Purple Biotech Ltd.股市,Purple Biotech Ltd.股票价格,Purple Biotech Ltd.股票交易,Purple Biotech Ltd.股票购买,Purple Biotech Ltd.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Purple Biotech Ltd.(PPBT),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Purple Biotech Ltd.(PPBT) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}